company background image
524506 logo

Coral Laboratories BSE:524506 Stock Report

Last Price

₹724.00

Market Cap

₹2.6b

7D

-0.1%

1Y

192.9%

Updated

15 Jul, 2024

Data

Company Financials

Coral Laboratories Limited

BSE:524506 Stock Report

Market Cap: ₹2.6b

524506 Stock Overview

Manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

524506 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Coral Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Coral Laboratories
Historical stock prices
Current Share Price₹724.00
52 Week High₹748.00
52 Week Low₹244.00
Beta1.15
11 Month Change26.74%
3 Month Change96.74%
1 Year Change192.88%
33 Year Change71.93%
5 Year Change299.56%
Change since IPO6,481.82%

Recent News & Updates

Recent updates

Shareholder Returns

524506IN PharmaceuticalsIN Market
7D-0.1%0.7%0.5%
1Y192.9%51.1%45.1%

Return vs Industry: 524506 exceeded the Indian Pharmaceuticals industry which returned 51.1% over the past year.

Return vs Market: 524506 exceeded the Indian Market which returned 45.1% over the past year.

Price Volatility

Is 524506's price volatile compared to industry and market?
524506 volatility
524506 Average Weekly Movement9.3%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 524506's share price has been volatile over the past 3 months.

Volatility Over Time: 524506's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1994109Girish Dhamejacorallab.com

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, anticold, antiallergic, anti-asthmatic, anti-diabetic, anthelmentic, thyroid, and anti-protozoal/anti-amebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products.

Coral Laboratories Limited Fundamentals Summary

How do Coral Laboratories's earnings and revenue compare to its market cap?
524506 fundamental statistics
Market cap₹2.59b
Earnings (TTM)₹157.89m
Revenue (TTM)₹836.60m

16.4x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524506 income statement (TTM)
Revenue₹836.60m
Cost of Revenue₹372.46m
Gross Profit₹464.14m
Other Expenses₹306.25m
Earnings₹157.89m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)44.19
Gross Margin55.48%
Net Profit Margin18.87%
Debt/Equity Ratio0%

How did 524506 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.